Marc E Buyse

12PUBLICATIONS
87CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingPredictive and prognostic markersCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 31, 2023
Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018).

Rebecca C Arend, Bradley J Monk, Ronnie Shapira-Frommer

|Oct 25, 2023
Design of a clinical trial using generalized pairwise comparisons to test a less intensive treatment regimen.

Mickaël De Backer, Manju Sengar, Vikram Mathews

|Aug 04, 2023
Time to deterioration of patient-reported outcomes as a surrogate of overall survival: a meta-analysis.

Adel Shahnam, Udit Nindra, Jayesh Desai

|Apr 19, 2023
Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer.

Marion T van Mackelenbergh, Sibylle Loibl, Michael Untch

|Mar 28, 2023
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy.

Pierre Squifflet, Everardo D Saad, Sibylle Loibl

|Apr 05, 2022
Surrogacy Beyond Prognosis: The Importance of "Trial-Level" Surrogacy.

Marc Buyse, Everardo D Saad, Tomasz Burzykowski

Pageof 2

Frequent Collaborators

6 joint publications

Everardo D Saad

2 joint publications

Luca Gianni

2 joint publications

Pierfranco Conte

2 joint publications

Michael Untch